摘要
对25例分化好的甲状腺癌术后转移灶有摄取131I功能者进行了131I治疗.按不同转移部位给予不同量的131I,其一次剂量为3.7~7.4GBq,累积剂量为3.7~29.6GBq,平均为9.45GBq.结果转移灶摄取131I功能完全消除者12例(48.0%),部分消除者8例(32.0%),好转后复发者1例(4.0%).无效或加重者4例(16.0%),总有效率84.0%.其中以颈部软组织转移者疗效最好,肺或肺与软组织转移者次之,骨或骨与软组织转移者最差.
Abstract patients with metastases from differentiated papillary,follicular and mixed thyroid cancer were treated with  ̄(131)I after surgery.These patients all demonstrated some concentration or  ̄(131)I within their metastatic foci,as seen by  ̄(131)I whole body imaging.Single doses varying from 3.7~7.4GBq were used, depending on extent of the disease and the site(s) of involvement.Total doses of 3.7~29.6GBq,average 9.45GBq,were given for proven mctastases. The results showed that metastascs as a result of  ̄(131)I concentration disappeared completely in 12 patients (48%),partly in 9 patients (36.0%) and responded poorly in 4 patients (16.0%) with a total effective rate of 84.0% (21/25).The effective rate was the highest for metastases in the cervical soft tissue,also high for metastases in the lung and the lowest for metastases in the bone.
出处
《中华核医学杂志》
CAS
CSCD
北大核心
1995年第1期32-34,共3页
Chinese Journal of Nuclear Medicine